These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 17492844)

  • 1. The role of topical calcineurin inhibitors for skin diseases other than atopic dermatitis.
    Wollina U
    Am J Clin Dermatol; 2007; 8(3):157-73. PubMed ID: 17492844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Off-Label Uses of Topical Calcineurin Inhibitors.
    Wong E; Kurian A
    Skin Therapy Lett; 2016 Jan; 21(1):8-10. PubMed ID: 27224898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of topical calcineurin inhibitors in atopic dermatitis.
    Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
    Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential new indications of topical calcineurin inhibitors.
    Luger T; Paul C
    Dermatology; 2007; 215 Suppl 1():45-54. PubMed ID: 18174692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas.
    Draelos ZD
    Curr Med Res Opin; 2008 Apr; 24(4):985-94. PubMed ID: 18284804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.
    Breuer K; Werfel T; Kapp A
    Am J Clin Dermatol; 2005; 6(2):65-77. PubMed ID: 15799678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of pimecrolimus cream in disorders other than atopic dermatitis.
    Day I; Lin AN
    J Cutan Med Surg; 2008; 12(1):17-26. PubMed ID: 18258153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovative use of topical calcineurin inhibitors.
    Lin AN
    Dermatol Clin; 2010 Jul; 28(3):535-45. PubMed ID: 20510763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Off-label Uses of Topical Pimecrolimus.
    Ladda M; Sandhu V; Ighani A; Yeung J
    J Cutan Med Surg; 2019; 23(4):442-448. PubMed ID: 31053034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical pimecrolimus for skin disease other than atopic dermatitis.
    Wollina U; Hansel G; Koch A; Abdel-Naser MB
    Expert Opin Pharmacother; 2006 Oct; 7(14):1967-75. PubMed ID: 17020422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus ointment: the treatment of atopic dermatitis and other inflammatory cutaneous disease.
    Carroll CL; Fleischer AB
    Expert Opin Pharmacother; 2004 Oct; 5(10):2127-37. PubMed ID: 15461548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update of calcineurin inhibitors to treat inverse psoriasis: A systematic review.
    Dattola A; Silvestri M; Bennardo L; Del Duca E; Longo C; Bianchi L; Nisticò S
    Dermatol Ther; 2018 Nov; 31(6):e12728. PubMed ID: 30295379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical calcineurin inhibitors for the treatment of vulvar dermatoses.
    Goldstein AT; Thaçi D; Luger T
    Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):22-9. PubMed ID: 19631446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcineurin inhibitors in pediatric atopic dermatitis: a review of current evidence.
    Kalavala M; Dohil MA
    Am J Clin Dermatol; 2011 Feb; 12(1):15-24. PubMed ID: 21067248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Topical treatment of vulvar lichen sclerosus with calcineurin inhibitors].
    Maassen MS; van Doorn HC
    Ned Tijdschr Geneeskd; 2012; 156(36):A3908. PubMed ID: 22951124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical macrolide immunomodulators: a role in the treatment of vitiligo?
    Tjioe M; Vissers WH; Gerritsen MJ
    Am J Clin Dermatol; 2006; 7(1):7-12. PubMed ID: 16489839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The treatment of atopic dermatitis in adults with topical calcineurin inhibitors].
    Meurer M; Wozel G
    Hautarzt; 2003 May; 54(5):424-31. PubMed ID: 12719862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical tacrolimus and pimecrolimus: future directions.
    Ling MR
    Semin Cutan Med Surg; 2001 Dec; 20(4):268-74. PubMed ID: 11770914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Off-Label Use of Topical Calcineurin Inhibitors in Dermatologic Disorders.
    Guenther L; Lynde C; Poulin Y
    J Cutan Med Surg; 2019; 23(4_suppl):27S-34S. PubMed ID: 31476936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antipruritic effects of pimecrolimus and tacrolimus].
    Ständer S; Luger TA
    Hautarzt; 2003 May; 54(5):413-7. PubMed ID: 12719860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.